Bbb International Pharma Private Limited - Company Profile

It is a food and beverages private limited company based in Andheri (West), Mumbai, Maharashtra, India, established in 2019.
2019 Andheri (West), Mumbai, Maharashtra, India Active
Last Updated:
About Bbb International Pharma Private Limited

Bbb International Pharma Private Limited, a active private limited company, was established on 24 May 2019 in Andheri (West), Mumbai, Maharashtra, India. Engaging in artificial fibres within the food and beverages sector, it holds CIN: U24304MH2019PTC325866. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.

Its leadership includes Ravi Rawat (Director), Munita Rameshwar Prasad (Additional Director). Past directors included Mohd Naveed Ansari. It is based at 103, Sundervan Crystal Chs Ltd. Sundervan Complex, Off J P Road, Andheri (West), Mumbai, Maharashtra, 400053.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304MH2019PTC325866

  • Registration Number

    325866

  • Incorporation Date

    24 May 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 6 Year, 8 Months
Company report

Bbb International Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bbb International Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Bbb International Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Ravi Rawat Director 24 May 2019 Current
Munita Rameshwar Prasad Additional Director 28 Jun 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 02 Jul 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bbb International Pharma.

Enhance accessibility to Bbb International Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Bbb International Pharma revenue growth over time
Bbb International Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bbb International Pharma?

Unlock access to Bbb International Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Bbb International Pharma?

Unlock and access historical data on people associated with Bbb International Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bbb International Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bbb International Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bbb International Pharma
Recent Activity within the Organization
  • Director Appointment

    Munita Rameshwar Prasad was appointed as a Additional Director was appointed as a Additional Director on 28 Jun 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.

  • Director Appointment

    Progress on Ravi Rawat was appointed as a Director was appointed as a Director on 24 May 2019 & has been associated with this company since 6 years 8 months . was documented.

  • Company Incorporation

    Progress on Bbb International Pharma Private Limited was registered on 24 May 2019 with Roc Mumbai & aged 6 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bbb International Pharma Private Limited?

The CIN of Bbb International Pharma Private Limited is U24304MH2019PTC325866.

Where is Bbb International Pharma Private Limited headquartered?

Bbb International Pharma Private Limited is headquartered at 103, Sundervan Crystal Chs Ltd. Sundervan Complex, Off J P Road, Andheri (West), Mumbai, Maharashtra, 400053.

When was Bbb International Pharma Private Limited incorporated?

Bbb International Pharma Private Limited was incorporated on 24 May 2019.

Who are the current directors of Bbb International Pharma Private Limited?

The current directors of Bbb International Pharma Private Limited are

What is the primary industry of Bbb International Pharma Private Limited?

The primary industry of Bbb International Pharma Private Limited is Food And Beverages.

Is Bbb International Pharma Private Limited a listed company?

Bbb International Pharma Private Limited is unlisted.

What is the capital structure of Bbb International Pharma Private Limited?

The authorized capital of Bbb International Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available